| PESAD13 | What are the practices of people attending erotica shows in terms of psychoactive substance use, sexual behavior and HIV testing? | Poster exhibition | Other populations vulnerable in specific contexts |
| EPA075 | What can we learn from the 2021 Aids Healthcare Foundation-Eswatini mortality profile after meeting the UNAIDS 95-95-95 target? | E-poster | HIV and co-morbidities |
| EPC284 | What is the added value of incorporating pleasure in sexual health interventions? A systematic review and meta-analysis | E-poster | Sexuality, gender and prevention technologies (including condoms, treatment as prevention, medical male circumcision, pre-exposure prophylaxis) |
| EPC154 | What is the best policy option for Indonesia to eliminate AIDS in 2030?: The Investment Case Analysis consideration | E-poster | Modelling future healthcare needs |
| EPE013 | What motivated men to start PrEP? A cross-section of men starting PrEP in Buffalo City Municipality, South Africa, want convenient, tailored platforms | E-poster | Implementation science of scaling up prevention (including PrEP) |
| EPD273 | What shapes people living with HIV's experience of stigma? A qualitative exploration of social-structural conditions | E-poster | Intersectional identities and multiple vulnerabilities to HIV and co-infections |
| EPB062 | What will it take to control the syphilis epidemic among gay, bisexual and other men who have sex with men (MSM) in British Columbia (BC), Canada? | E-poster | STIs (including HPV) |
| OALBE0104 | What women want - results from discrete choice experiment about preferred PrEP method from Khomas region of Namibia | Oral abstract session with live Q&A | Implementation science of scaling up prevention (including PrEP) |
| EPC447 | When pandemics collide: impact of the COVID-19 pandemic on HIV and STI testing, treatment and PrEP use in a Boston community health center | E-poster | Effects of the COVID-19 on HIV epidemiology and prevention |
| EPE205 | When the only intervention left to optimise is retention: Comparing the 2021 and 2016 South African HIV Investment Cases | E-poster | National financing analyses and financing mechanisms for HIV, hepatitis and STI programmes and services |